Research shows why cancer stops responding to kinase-blocking drugs and comes back stronger

Research shows why cancer stops responding to kinase-blocking drugs and comes back stronger
More than 70 FDA-approved cancer drugs are kinase inhibitors, which work by blocking kinases — enzymes that add phosphate groups to molecules in the cell — and preventing the chemical activity necessary for signaling and growth in cancer cells…

Published March 13, 2023 at 06:45AM
Read more at nsf.gov

Comments

Popular posts from this blog

NSF names two new Innovation Engines in North Carolina, announces $30 Million in new investments to region

NSF and AFGE sign new collective bargaining agreement

NSF invests $19.6M in emerging research institutions to grow their capacity to participate in regional innovation ecosystems and announces next funding opportunity